Huaren Pharmaceutical Co., Ltd. (300110.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap3.72B
Enterprise Value4.19B
P/E Ratio-7.9
PEG Ratio-0.13
Price/Sales Ratio2.88
Price/Book Ratio4.33
Enterprise/Revenue3.46
Enterprise/EBITDA-13.15

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.36
Operating Margin-0.35
AD

Management Effectiveness

Return On Assets-0.17
Return On Equity-0.48

Income Statement

Revenue1.32B
Revenue/Share1.1
Gross Profit489.54M
EBITDA-308.5M
Net Income-462.9M
Diluted EPS-0.39

Balance Sheet

Total Cash212.74M
Total Cash/Share0.18
Total Debt976.37M
Total Debt/Equity1.13
Current Ratio0.8
Book Value Per Share0.8

Price History

52-Week Change-1.86
52-Week High3.98
52-Week Low2.41
Moving Average 50 Days2.89
Moving Average 200 Days3.02

Statistics

Average Volume47.53M
Shares Outstanding1.18B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.05
Last Split Factor287:250
Last Split DateFebruary 09, 2018
AD